📊 Backtest📒 Journal Updated 13/08/2026
← 🔥 Turbo
📐 Simulate Position
STALE?Report written 16 days ago · at $2.57entry levels may be stale — re-check before acting

RZLV

MoonshotSMALL CAP
Rezolve AI PLC · NASDAQ · Technology / AI Software (Agentic Commerce)
$2.57
▲ 5.76%
MCap $1.02B
Self-fetched today (Aug 4). Closed $2.57 Aug 3 (+5.76%), still ~70% below the 52-week high ($8.45). The market has now digested the Jul 27 preliminary H1 print (revenue $127M, ~20x YoY, $360M FY26 guide reaffirmed) with only a muted +3.1% same-day reaction — real evidence execution/credibility skepticism persists. The prior report's 'fully funded, zero requirement for additional operational equity' framing needs correcting: the FY2025 20-F (filed Mar 30, 2026) explicitly discloses substantial doubt about the company's ability to continue as a going concern.
BusinessAgentic AI commerce platform · H1 2026 revenue $127M (~20x YoY), reaffirmed $360M FY26 guide · TCS/Zilch/Microsoft reseller partnerships · FY2025 20-F now discloses explicit going-concern doubt — trading ~70% below its 52-week high
Thesis

Rezolve AI delivered H1 2026 revenue of $127M (~20x YoY) and reaffirmed its $360M FY26 guide on Jul 27, backed by enterprise resale partnerships with Tata Consultancy Services, Zilch, and Microsoft and 1,000+ enterprise customers — but the stock only rose 3.1% on that print, a sign the market isn't fully buying the story yet. The bigger update since the last report: the FY2025 20-F (filed Mar 30, 2026) explicitly states 'substantial doubt about our ability to continue as a going concern for at least one year,' citing an $87.1M working-capital deficit and $104M+ of current debt against $111.1M cash, with management's mitigation plan leaning on cost cuts, debt refinancing, and an active ATM equity program with 'substantial available capacity.' ⚠️ SURVIVAL: this is a real, disclosed liquidity/dilution risk, not a hypothetical — but RZLV stays in the moonshot lane because the growth is independently verified (20x revenue, unanimous 5/6-analyst Buy coverage, $10.75 average target), the going-concern language is common for pre-profitability micro-caps racing toward a stated year-end profitability inflection, and the Oct 7 Q3 print is a genuine binary catalyst for both execution and survival. Size well below a standard moonshot allocation given the disclosure.

📝 Primary Verdict · Core Holding
SPECULATIVEMoonshot

ค่าขนม / Moonshot — small position on the confirmed 20x revenue growth and TCS/Zilch/Microsoft traction, sized down from a standard moonshot allocation given the FY2025 20-F's explicit going-concern disclosure; Oct 7 Q3 earnings is the real test of both execution and survival.

81
score / 100 ⓘ
⚡ Catalyst
📊 Q3/FY26 Earnings Report~9 WEEKS

Rezolve's next full earnings report and the real confirmation test — the Jul 27 preliminary H1 print (20x YoY revenue, guidance reaffirmed) only produced a muted +3.1% reaction. Q3 needs to show GAAP progress toward management's stated year-end profitability inflection and address the FY2025 20-F's going-concern language, not just repeat top-line growth.

Oct 7, 2026
🤝 TCS / Zilch / Microsoft Reseller RampONGOING

Management now directly credits enterprise resale partnerships with Tata Consultancy Services, Zilch, and Microsoft for the H1 revenue step-up (1,000+ enterprise customers, up from 950+) — an ongoing distribution catalyst if H2 deal flow keeps accelerating toward the $360M full-year guide.

Ongoing
💰 $300M Buyback AuthorizationONGOING

Board-approved buyback remains outstanding and unexecuted as of early Aug 2026 — a potential technical floor if management begins repurchasing at current depressed levels, though the FY2025 going-concern disclosure raises real questions about prioritizing buybacks over liquidity preservation.

Ongoing
🎯 Entry Point
Entry 1
$2.57
Current price — up 5.8% Aug 3, still ~70% below the 52-week highScale in (small)
Entry 2PREFERRED
$2.05–2.25
Near the 52-week low ($2.05) — best R/R if the going-concern overhang keeps the stock pinned into Oct 7 earningsIf dips
Entry 3
$1.60
Deep capitulation — a dilution-driven selloff, escalated going-concern language, or a Q3 guidance cutDeep dip only
✅ Take Profit
TP1
Base — Oct 7 Q3 print confirms H1 momentum; market re-rates for the growth without fully resolving the going-concern discount
$4.5
+75%
TP2
Bull — clean Q3 beat plus visible progress toward the stated year-end profitability inflection
$8
+211.3%
TP3 🌙
Moon — beat + profitability inflection confirmed, going-concern language removed from the next annual filing, hits full analyst consensus
$10.75
+318.3%
🔴 Stop Loss
Tight Stop
Below the 52-week low — thesis-neutral technical breakdown but momentum failing
$1.85
-28%
Hard Stop
Deep breach — going-concern language escalates, ATM issuance accelerates sharply, or Oct 7 brings a guidance cut
$1.3
-49.4%
Risk / Reward
From Entry 2 ($2.15 mid) tight stop vs TP2
19.5 : 1
⚠ High R/R on paper, but the disclosed going-concern risk means the real tail scenario is dilution/failure, not just a stop-loss breach — size well below a standard moonshot allocation
📅 Estimate Date
Q3/FY26 Earnings
Needs to show GAAP progress toward the year-end profitability claim and address the going-concern language, not just reaffirm the $360M revenue guide
Oct 7, 2026
Guidance reaffirmation expected; GAAP/margin progress needed to rebuild credibility
📈 Possible Up % — Scenario Spread
Bear
-45%
$1.41
Base
+75%
$4.5
Bull
+211%
$8
Moon
+318%
$10.75
← downsideupside →
🏛️ Fed / Macro Risk — MEDIUM

Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution

Rate Outlook
Fed held at 3.50-3.75% on Jul 29, 2026 with 3 hawkish dissents favoring a hike — rate-hike tail risk into year-end hasn't gone away.
Inflation
Core PCE still 3.3% YoY, well above the 2% target, with the 10-year yield elevated — a headwind for unprofitable growth software valuations generally.
Sector Impact
RZLV's own going-concern/dilution overhang matters far more than macro right now, but higher-for-longer rates raise the cost of the debt refinancing and additional ATM issuance management is already leaning on to fund operations.
Summary
MEDIUM — macro is secondary to RZLV's company-specific survival and execution risk, but a hawkish surprise would make the debt refinancing/ATM path in the FY2025 going-concern mitigation plan more expensive and more dilutive at the margin.
🎯 Analyst Targets

Wall Street price targets vs the current price — cross-check our TP levels

Consensus (5-6 analysts)
Strong Buy$10.75+318%
Roth Capital
Buy$12.5+386%
H.C. Wainwright
Buy$12+367%
Cantor Fitzgerald
Buy$8+211%
Northland Securities
Buy$7+172%
current price $2.57
🔍 Similar-Catalyst Comparable Check

Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic

RZLV⚡ MixedJul 27, 2026
+3.1%
in 1 day
Muted +3.1% stock reaction to Jul 27 preliminary H1 2026 print (revenue ~20x YoY, $360M guide reaffirmed)
Same-company precedent showing the market is discounting even a very strong beat because of the going-concern/dilution overhang — the credibility gap this stock carries into Oct 7 earnings.
BBAI❌ BadMay 2025
-11.3%
in 1 day
Q1 2025 EPS/revenue miss — dilution-risk AI micro-cap punished on a bad print
BigBear.ai, a similarly dilution/ATM-dependent AI micro-cap, fell 11.3% the day after missing Q1 2025 estimates — a real base rate for how a Q3 miss could hit RZLV given its own going-concern overhang.
BBAI✅ GoodMar 2, 2026
+0%
in 0 days
ATM-funded balance-sheet turnaround — 90%+ debt reduction, $693M raised via equity facilities, ended FY2025 with $462M cash
Shows an ATM/dilution-dependent AI micro-cap can use the same mechanism RZLV is now relying on to genuinely fix its balance sheet rather than just delay failure — the bull-case survival path for RZLV's own going-concern mitigation plan.
GOEV❌ BadJan 2025
-99%
in 365 days
Going-concern doubt disclosed but never resolved — Chapter 7 bankruptcy filing and Nasdaq delisting
Canoo disclosed the same kind of going-concern language RZLV's FY2025 20-F now carries, was unable to secure sufficient additional funding, and ultimately filed Chapter 7 and was delisted — the real tail-risk case for why RZLV's survival flag matters and sizing must stay disciplined.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode

Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.

⚠️

Use this stop-loss set (-28% / -35%) only when trading the earnings spot — not for the core holding (use the -28% / -49.4% set above). If you are holding long-term, follow the core set.

📈Pre-Catalyst Run-up Pattern
0% to +8% pre-event driftminimal pre-earnings runup; the move is expected to happen on the print itself

Small-cap AI-software names carrying a disclosed going-concern/credibility gap tend to stay range-bound into the confirming earnings print rather than running up beforehand — RZLV's own muted +3.1% reaction to a huge Jul 27 beat is direct evidence of this pattern heading into Oct 7.

🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +8%
range: +3% to +15%· Jul 27, 2026 (RZLV)
RZLV's own Jul 27, 2026 preliminary H1 print (~20x YoY revenue beat, guidance reaffirmed) produced only a +3.1% same-day reaction — real evidence the market is discounting execution/going-concern risk even on strong prints. A cleaner Q3 beat with visible profitability progress could produce a larger relief rally given elevated short interest, but the realistic base rate here is muted, not explosive.
❌ Catalyst Missavg -25%
range: -11% to -70%· May 2025 (BBAI); H1 2026 (RZLV)
RZLV's own stock has fallen as much as ~70% from its 52-week high on execution/credibility doubts even without a confirmed miss. Comparable dilution-risk AI micro-cap BigBear.ai (BBAI) fell 11.3% same-day after missing Q1 2025 EPS/revenue estimates — a same-sector base rate for how a Q3 miss could be punished on top of RZLV's own going-concern overhang.
💼Spot Position Sizing
How the recommended % is derived
3%
of portfolio

The FY2025 20-F's explicit going-concern disclosure and active ATM program materially raise survival/dilution risk versus the prior report's 'fully funded' framing — sizing capped below the moonshot ceiling despite the genuinely strong 20x revenue growth.

🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-28%($1.85)
Below the 52-week low ahead of the Oct 7 print — thesis-neutral but signals the going-concern overhang is dominating sentiment
After Catalyst (Bad Result)-35%
A Q3 miss, guidance cut, or escalated going-concern language in the next filing would confirm the market's skepticism — exit
📎 Sources

Generated 2026-08-04 · Not financial advice